Intrexon Announces First Quarter 2015 Financial Results
- Net income of $27.1 million or $0.26 per basic share - - Adjusted EBITDA of $(11.3 million) or $(0.11) per basic share - - Declares Special Stock Dividend of ZIOPHARM Shares - GERMANTOWN, Md., May 11, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first quarter results for 2015.  Business Highlights and Recent Developments: Entered into an exclusive collaboration and license agreement with the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, to develop and commercialize chimeric antigen receptor T-cell (CAR-T) cancer therapies. Utilizing Intrexon's cell engineering techniques and RheoSwitch® platfor...
Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015
GERMANTOWN, Md., May 4, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced it will release first quarter 2015 financial results after the market closes on May 11, 2015.  The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update. The conference call may be accessed by dialing 1-888-346-3959 (Domestic US) and 1-412-902-4262 (International) and asking to join the "Intrexon Conference Call."  Participants may also access the live webcast through Intrexon's website in the Investors section under Calendar of Events. About Intrexon Corporation Intrexon Corporation (NYSE: XON) is a leader in synthetic biolog...
Intrexon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
GERMANTOWN, Md., April 30, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer, and Krish Krishnan, Chief Operating Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12th, at 8:40 a.m. Pacific Standard Time at Encore at the Wynn, Las Vegas, Nevada. About Intrexon Corporation Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer sectors to create biologically-based products that improve the quality of life and the health of the ...
Intrexon Completes Acquisition of Okanagan Specialty Fruits
Healthy Produce Choices for Consumers With Benefits Across Entire Supply Chain GERMANTOWN, Md., April 20, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has completed the acquisition of Okanagan Specialty Fruits (OSF), the pioneering agricultural company behind the Arctic® apple, the world's first non-browning apple without the use of any flavor-altering chemical or antioxidant additives. OSF's vision and ground-breaking effort in responsibly harnessing the power of technology to produce wholesome, nutritious food that is more appetizing and convenient to consumers is aligned with Intrexon's strategy in the Food sector. The combi...
1